United States - English - NLM (National Library of Medicine)

xgen pharmaceuticals djb, inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin 300 mg in 1 ml - lincomycin injection, usp is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of cdad, as described in the boxed warning , before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives. indicated surgical procedures should be performed in conjunction with antibacterial therapy. lincomycin injection may be administered concomitantly with other antimicrobial agents when indicated. lincomycin is not indicated in the treatment of minor bacterial infections or viral infections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of lincomycin and other antibacterial drugs, lincomycin should be used only to treat or prevent infections that are proven or strongly suspected

Ireland - English - HPRA (Health Products Regulatory Authority)

huvepharma nv - neomycin sulfate; lincomycin hydrochloride - intramammary solution - 330/100 mg/syringe - lincomycin, combinations with other antibacterials; neomycin, combinations with other antibacterials

United States - English - NLM (National Library of Medicine)

general injectables and vaccines, inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - this drug is contraindicated in patients previously found to be hypersensitive to lincomycin or clindamycin.

United States - English - NLM (National Library of Medicine)

henry schein, inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - this drug is contraindicated in patients previously found to be hypersensitive to lincomycin or clindamycin.

Ireland - English - HPRA (Health Products Regulatory Authority)

huvepharma nv - lincomycin hydrochloride; neomycin sulfate - intramammary solution - 330, 100 mg/syringe - lincomycin, combinations with other antibacterials - cattle - antibacterial

United States - English - NLM (National Library of Medicine)

zoetis inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f), spectinomycin sulfate tetrahydrate (unii: ys91p54918) (spectinomycin - unii:93aki1u6qf) - lincomycin 16.7 g in 75 g - for use in chickens up to 7 days of age as an aid in the control of: airsacculitis caused by either mycoplasma synoviae or mycoplasma gallisepticum susceptible to lincomycin-spectinomycin. complicated chronic respiratory disease (air sac infection) caused by escherichia coli and m. gallisepticum susceptible to lincomycin-spectinomycin. complicated chronic respiratory disease (air sac infection) caused by escherichia coli and m. gallisepticum susceptible to lincomycin-spectinomycin.

United States - English - NLM (National Library of Medicine)

armas pharmaceuticals inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin injection is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of cdad, as described in the boxed warning , before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives. indicated surgical procedures should be performed in conjunction with antibacterial therapy. lincomycin injection may be administered concomitantly with other antimicrobial agents when indicated. lincomycin is not indicated in the treatment of minor bacterial infections or viral infections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of lincomycin and other antibacterial drugs, lincomycin should be used only to treat or prevent infections that are proven or strongly suspected to be c

United States - English - NLM (National Library of Medicine)

armas pharmaceuticals inc. - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin injection is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of cdad, as described in the boxed warning , before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives. indicated surgical procedures should be performed in conjunction with antibacterial therapy. lincomycin injection may be administered concomitantly with other antimicrobial agents when indicated. lincomycin is not indicated in the treatment of minor bacterial infections or viral infections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of lincomycin and other antibacterial drugs, lincomycin should be used only to treat or prevent infections that are proven or strongly suspected to be c

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

huvepharma sa-nv - neomycin sulfate - eq. neomycin 100 mg/10 ml; lincomycin hydrochloride - eq. lincomycin 330 mg/10 ml - intramammary solution - 10 mg/ml - 33 mg/ml - lincomycin hydrochloride; neomycin sulfate - lincomycin - cattle

United States - English - NLM (National Library of Medicine)

a-s medication solutions - lincomycin hydrochloride (unii: m6t05z2b68) (lincomycin - unii:bod072yw0f) - lincomycin injection, usp is indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of cdad, as described in the boxed warning , before selecting lincomycin the physician should consider the nature of the infection and the suitability of other alternatives. indicated surgical procedures should be performed in conjunction with antibacterial therapy. lincomycin injection may be administered concomitantly with other antimicrobial agents when indicated. lincomycin is not indicated in the treatment of minor bacterial infections or viral infections. to reduce the development of drug-resistant bacteria and maintain the effectiveness of lincomycin and other antibacterial drugs, lincomycin should be used only to treat or prevent infections that are proven or strongly suspected